Live Breaking News & Updates on ப்ரோடியஸ் டிஜிட்டல்
Stay updated with breaking news from ப்ரோடியஸ் டிஜிட்டல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Latest Trending Report on Connected Medical Technology Market Growing Technology Trends and Business Opportunities by 2027 | Nonin Medical, NuvoAir, Philips, Roche, PhysIQ, General Electric, Drägerwerk, Fresenius Medical Care, Medtronic, Myontec and more. – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Les 100 pionniers technologiques du WEF paperjam.lu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from paperjam.lu Daily Mail and Mail on Sunday newspapers.
Smart Pills Technology Market May see a Big Move | Major Giants Medtronic, Philips Healthcare, IntroMedic sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Smart Pills Technology Market May see a Big Move | Major Giants Medtronic, Philips Healthcare, IntroMedic texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Share Otsuka Pharmaceutical and Click Therapeutics have announced the launch of a new, fully remote clinical trial being conducted on Verily s Project Baseline platform. Called the Mirai study, it will be measuring a digital therapeutics intervention s effectiveness in reducing symptoms of depression among adults who have a major depressive disorder (MDD) diagnosis and are on antidepressant monotherapy. Christoph Koenen, EVP and chief medical officer of Ostuka Pharmaceutical Companies U.S., told MobiHealthNews that the pivotal, randomized, controlled trial will enroll as many as 540 patients across the country over 10 weeks of active participation. The study will be measuring safety and participants change from baseline on the Montgomery-Åsberg Depression Rating Scale, a standardized measure of depressive symptoms. ....